Pelthos Therapeutics Inc. (PTHS) AI Stock Price Forecast & Investment Analysis
Latest Analysis Date: July 18, 2025
Pelthos Therapeutics Inc. (PTHS) - Comprehensive Stock Analysis & Investment Research
Company Overview & Business Profile
Pelthos Therapeutics Inc. (Stock Symbol: PTHS)
is a leading company in the Life Sciences sector
, specifically operating within the Biological Products, (No Diagnostic Substances) industry.
.
The company has established itself as
an emerging investment opportunity with substantial growth potential.
Financial Performance & Key Metrics Analysis
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Pelthos Therapeutics Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
Pelthos Therapeutics Inc. strategically competes in the highly dynamic
Biological Products, (No Diagnostic Substances) marketplace,
representing an emerging small-cap investment with substantial growth potential and market disruption capabilities
.
.
Pelthos Therapeutics Inc. Stock Price Chart and Technical Analysis
Loading chart data...
Loading Pelthos Therapeutics Inc. interactive price chart and technical analysis...
Deep dive into Pelthos Therapeutics Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if Pelthos Therapeutics Inc. stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For Pelthos Therapeutics Inc.:
Book Value/Share$-0.68
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently Pelthos Therapeutics Inc. converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For Pelthos Therapeutics Inc.:
Understanding Financial Health Metrics
What these metrics mean: These ratios assess Pelthos Therapeutics Inc.'s ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For Pelthos Therapeutics Inc.:
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal Pelthos Therapeutics Inc.'s ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For Pelthos Therapeutics Inc.:
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively Pelthos Therapeutics Inc. uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For Pelthos Therapeutics Inc.:
Understanding Financial Statement Data
What these metrics mean: Key figures from Pelthos Therapeutics Inc.'s income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
For Pelthos Therapeutics Inc.:
Income Statement ($ Millions)
Balance Sheet Highlights ($ Millions)
Dividend & Shareholder Information
Shares Outstanding6M
Pelthos Therapeutics Inc. (PTHS) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Pelthos Therapeutics Inc. stock analysis.
Loading fundamental data...
Loading Pelthos Therapeutics Inc. comprehensive fundamental analysis and insider trading data...
Latest Pelthos Therapeutics Inc. Stock News & Market Analysis
Breaking news, analyst reports, and market updates affecting Pelthos Therapeutics Inc. (PTHS) stock price and investment outlook.
agreed to combine Ligand's wholly owned subsidiaries, Pelthos Therapeutics Inc. and LNHC, Inc. (collectively Pelthos), with CHRO Merger Sub Inc., a wholly owned subsidiary of Channel.
Pelthos Therapeutics Inc. (NYSE:PTHS) on Thursday announced the launch of Zelsuvmi (berdazimer) topical gel 10.3% for molluscum contagiosum (molluscum) in adults and pediatric patients one year of ...
Combined company will operate under the name “Pelthos Therapeutics Inc.” and will trade on the NYSE American exchange under the ticker symbol “PTHS” starting on July 2, 2025 ...
About Pelthos Therapeutics Inc. Channel Therapeutics Corp. is a clinical-stage biotech company that engages in the development and commercialization of therapeutics. It focuses on non-opioid ...
Files Quarterly Report on Form 10-Q detailing financial results for legacy operations for the three and six months ended June 30, 2025Strong physician response following successful launch of ZELSUVMI ...
Pelthos Therapeutics Inc. (NYSE:PTHS) on Thursday announced the launch of Zelsuvmi (berdazimer) topical gel 10.3% for molluscum contagiosum (molluscum) in adults and pediatric patients one year of ...
Learn about the executive team and board of directors at Pelthos Therapeutics Inc (PTHS:XASE) and review their bios and compensation over the latest fiscal years.
Pelthos Therapeutics Inc. Competitors & Peer Analysis - Life Sciences Sector
Comparative analysis of Pelthos Therapeutics Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.
Frequently Asked Questions - Pelthos Therapeutics Inc. Stock Forecast
How accurate are Pelthos Therapeutics Inc. stock predictions?
Our AI model demonstrates 14% historical accuracy for PTHS predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence Pelthos Therapeutics Inc. stock price forecasts?
Is Pelthos Therapeutics Inc. a good investment in 2025?
Based on our AI analysis, Pelthos Therapeutics Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are Pelthos Therapeutics Inc. forecasts updated?
Pelthos Therapeutics Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced Pelthos Therapeutics Inc. Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Pelthos Therapeutics Inc. stock.
